Harbottle RP - Search Results

1

Strategies for the episomal modification of cells.

Wong SP, Argyros O, Coutelle C, Harbottle RP. Wong SP, et al. Among authors: harbottle rp. Curr Opin Mol Ther. 2009 Aug;11(4):433-41. Curr Opin Mol Ther. 2009. PMID: 19649988 Review.

2

Non-viral episomal modification of cells using S/MAR elements.

Argyros O, Wong SP, Harbottle RP. Argyros O, et al. Among authors: harbottle rp. Expert Opin Biol Ther. 2011 Sep;11(9):1177-91. doi: 10.1517/14712598.2011.582035. Epub 2011 May 9. Expert Opin Biol Ther. 2011. PMID: 21548848 Review.

3

Vector systems for prenatal gene therapy: principles of non-viral vector design and production.

Wong SP, Argyros O, Harbottle RP. Wong SP, et al. Among authors: harbottle rp. Methods Mol Biol. 2012;891:133-67. doi: 10.1007/978-1-61779-873-3_7. Methods Mol Biol. 2012. PMID: 22648771

4

Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector.

Argyros O, Wong SP, Niceta M, Waddington SN, Howe SJ, Coutelle C, Miller AD, Harbottle RP. Argyros O, et al. Among authors: harbottle rp. Gene Ther. 2008 Dec;15(24):1593-605. doi: 10.1038/gt.2008.113. Epub 2008 Jul 17. Gene Ther. 2008. PMID: 18633447

5

Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantage.

Wong SP, Argyros O, Coutelle C, Harbottle RP. Wong SP, et al. Among authors: harbottle rp. Gene Ther. 2011 Jan;18(1):82-7. doi: 10.1038/gt.2010.116. Epub 2010 Aug 26. Gene Ther. 2011. PMID: 20739959

6

Genetic modification of cancer cells using non-viral, episomal S/MAR vectors for in vivo tumour modelling.

Argyros O, Wong SP, Gowers K, Harbottle RP. Argyros O, et al. Among authors: harbottle rp. PLoS One. 2012;7(10):e47920. doi: 10.1371/journal.pone.0047920. Epub 2012 Oct 26. PLoS One. 2012. PMID: 23110132 Free PMC article.

7

High-throughput Pyrosequencing of a phage display library for the identification of enriched target-specific peptides.

Rahim A, Coutelle C, Harbottle R. Rahim A, et al. Biotechniques. 2003 Aug;35(2):317-20, 322, 324. doi: 10.2144/03352st04. Biotechniques. 2003. PMID: 12951773 Free article.

8

Development of a self-assembling nuclear targeting vector system based on the tetracycline repressor protein.

Vaysse L, Harbottle R, Bigger B, Bergau A, Tolmachov O, Coutelle C. Vaysse L, et al. J Biol Chem. 2004 Feb 13;279(7):5555-64. doi: 10.1074/jbc.M311894200. Epub 2003 Nov 7. J Biol Chem. 2004. PMID: 14607832 Free article.

9

Nuclear-targeted minicircle to enhance gene transfer with non-viral vectors in vitro and in vivo.

Vaysse L, Gregory LG, Harbottle RP, Perouzel E, Tolmachov O, Coutelle C. Vaysse L, et al. Among authors: harbottle rp. J Gene Med. 2006 Jun;8(6):754-63. doi: 10.1002/jgm.883. J Gene Med. 2006. PMID: 16532508

10

pEPito: a significantly improved non-viral episomal expression vector for mammalian cells.

Haase R, Argyros O, Wong SP, Harbottle RP, Lipps HJ, Ogris M, Magnusson T, Vizoso Pinto MG, Haas J, Baiker A. Haase R, et al. Among authors: harbottle rp. BMC Biotechnol. 2010 Mar 15;10:20. doi: 10.1186/1472-6750-10-20. BMC Biotechnol. 2010. PMID: 20230618 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page